Huntington's Disease Trial, Recruiting NCT02855476 Sponsor: University College, London Condition: Huntington's Disease
Back to Huntingtons Disease

Huntington's Disease Trial, Recruiting

NCT02855476
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18–75 years (for healthy controls, or people with early or late pre-symptomatic HD, or those with an incomplete form of the HD gene change), adults aged 21–75 years (for people with early, moderate, or advanced HD symptoms), or children aged 11 and older (for juvenile HD)
  • You must be enrolling as an HD participant (someone with or at risk for Huntington's disease)
  • You are able to give your own consent to take part, or you have a legal representative (such as a parent or guardian for younger participants) who can consent on your behalf
  • You are able to follow and complete the study procedures as required
  • All participants except family or community controls must have already had a genetic test for HD

Who may not be able to join:

  • You have taken part in a drug trial within the last 30 days before any study visit
  • You have changed certain medications — such as antidepressants, mental health medications, or other drugs or supplements used to treat HD — within the last 30 days
  • You have taken blood-thinning or anti-clotting medication within the last 14 days
  • You have a serious other health condition that may interfere with the study
  • You have a fear of needles, frequent headaches, or have had spinal surgery or a spinal condition (confirm with trial site)
  • You have a disorder that affects how your blood clots or causes unusual bruising
  • Your screening blood test results are more than 10% outside the normal range
  • You have a problem with drug or alcohol misuse
  • You have a positive pregnancy test at any point during the screening or study visit (for women who could become pregnant)
  • There are concerns that you would not be able or willing to follow the study requirements
  • You have had a serious reaction to procedures in this study, or you have had a lumbar puncture (spinal tap) for any reason in the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2017
Est. completion
30 April 2027

Where this trial is recruiting

🇨🇦 Canada 🇫🇷 France 🇩🇪 Germany 🇮🇹 Italy 🇳🇿 New Zealand 🇵🇱 Poland 🇵🇹 Portugal 🇪🇸 Spain 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

The primary objective of this study is:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov